Patents by Inventor Mina Fogel

Mina Fogel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of L1 and ADAM10 for the treatment of carcinomas
    Patent number: 8003599
    Abstract: Described is a pharmaceutical composition comprising a compound(s) interfering with the biological activity of L1 and/or ADAM10 or their expression. Also described is the use of said compound(s) for the prevention/treatment of carcinomas like ovarian and endometrial carcinoma. Finally, the diagnosis of highly malignant forms of carcinomas which is based on the determination of the activity/expression of L1 and/or ADAM10 is described.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: August 23, 2011
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Peter Altevogt, Daniela Kelm, Mina Fogel
  • Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
    Patent number: 7670601
    Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: March 2, 2010
    Assignees: Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts, Mor Research Applications, Ltd.
    Inventors: Peter Altevogt, Mina Fogel
  • Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
    Patent number: 7618785
    Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: November 17, 2009
    Assignees: Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts, Mor Research Applications, Ltd.
    Inventors: Peter Altevogt, Mina Fogel
  • DIAGNOSTIC AND THERAPEUTIC METHODS BASED ON THE L1 ADHESION MOLECULE FOR OVARIAN AND ENDOMETRIAL TUMORS
    Publication number: 20080138331
    Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
    Type: Application
    Filed: October 2, 2007
    Publication date: June 12, 2008
    Applicants: Mor Research Applications, Ltd., Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
    Inventors: Peter Altevogt, Mina Fogel
  • Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
    Publication number: 20040259084
    Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
    Type: Application
    Filed: May 19, 2003
    Publication date: December 23, 2004
    Inventors: Peter Altevogt, Mina Fogel